Oliver A. Zill

3.0k citations

24 papers · 1.9k indexed · 2 hit papers · h-index 12

Cancer Research top 1%
Pulmonary and Respiratory Medicine top 2%
Molecular Biology top 10%
Oncology top 5%
Pathology and Forensic Medicine top 5%

Co-authors: Richard B. Lanman Stefanie Mortimer Helmy Eltoukhy Jasper Rine Arthur M. Baca Kimberly C. Banks AmirAli Talasaz Eric A. Collisson
Topics: Cancer Genomics and Diagnostics (17 papers)Lung Cancer Treatments and Mutations (13 papers)Genetic factors in colorectal cancer (9 papers)
Cited by: Cancer Research Oncology Pulmonary and Respiratory Medicine
Journals: Nature Communications Journal of Clinical Oncology Genes & Development
Partner nations: United States Switzerland South Korea

In The Last Decade

Oliver A. Zill

24 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA

2015 470 citations Richard B. Lanman, Stefanie Mortimer et al. PLoS ONE profile →
The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients

2018 271 citations Oliver A. Zill, Kimberly C. Banks et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Oliver A. Zill

Since Specialization

Citations

This map shows the geographic impact of Oliver A. Zill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver A. Zill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver A. Zill more than expected).

Fields of papers citing papers by Oliver A. Zill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver A. Zill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver A. Zill. The network helps show where Oliver A. Zill may publish in the future.

Co-authorship network of co-authors of Oliver A. Zill

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver A. Zill. A scholar is included among the top collaborators of Oliver A. Zill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver A. Zill. Oliver A. Zill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Single-cell analysis reveals clonally expanded tumor-associated CD57 ⁺ CD8 T cells are enriched in the periphery of patients with metastatic urothelial cancer responding to PD-L1 blockade 2022 ·Journal for ImmunoTherapy of Cancer ·Michael Fehlings,Leesun Kim,Xiangnan Guan,Kobe Yuen,(unknown),Shomyseh Sanjabi,Oliver A. Zill,Deepali Rishipathak,Andrew J. Wallace,Alessandra Nardin,Siming Ma,(unknown),Evan W. Newell,Sanjeev Mariathasan,Mahesh Yadav	26
2	ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer 2022 ·Nature Communications ·Radia Marie Johnson,Xueping Qu,(unknown),Ling‐Yuh Huw,Avinashnarayan Venkatanarayan,Ethan Sokol,Fang‐Shu Ou,Nnamdi Ihuegbu,Oliver A. Zill,Omar Kabbarah,Lisa Wang,Richard Bourgon,Felipe de Sousa e Melo,(unknown),Anneleen Daemen,Alan P. Venook,Federico Innocenti,Heinz‐Josef Lenz,Carlos Bais	24
3	Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies 2021 ·Journal for ImmunoTherapy of Cancer ·(unknown),Andrew J. Wallace,(unknown),(unknown),(unknown),(unknown),Thomas D. Wu,Richard Bourgon,Ryan Jones,(unknown),Guang‐Yu Yang,Oliver A. Zill	10
4	Automated Dissection Protocol for Tumor Enrichment in Low Tumor Content Tissues 2021 ·Journal of Visualized Experiments ·(unknown),Oliver A. Zill,(unknown),Jeffrey Hung,(unknown),(unknown),Jennifer M. Giltnane,Justin M. Balko,Andrew J. Wallace,(unknown),(unknown),(unknown),(unknown),(unknown)	1
5	Abstract LB-063: ARID1A mutations induce an EGFR-like gene expression signature and confer intrinsic and acquired resistance to cetuximab treatment in first line metastatic CRC 2020 ·Cancer Research ·Radia Marie Johnson,Xueping Qu,Joshua D. Thomas,(unknown),Ling‐Yuh Huw,Fang‐Shu Ou,Ethan S. Sokol,Nnamdi Ihuegbu,Oliver A. Zill,Omar Kabbarah,Anneleen Daemen,Richard Bourgon,(unknown),Federico Innocenti,Heinz‐Josef Lenz,Felipe de Sousa e Melo,Carlos Bais	2
6	Validation of a Plasma-Based Comprehensive Cancer Genotyping Assay Utilizing Orthogonal Tissue- and Plasma-Based Methodologies 2018 ·Clinical Cancer Research ·Justin I. Odegaard,John J. Vincent,Stefanie Mortimer,James V. Vowles,Bryan C. Ulrich,Kimberly C. Banks,Stephen R. Fairclough,Oliver A. Zill,Marcin Sikora,Reza Bayat Mokhtari,Diana Abdueva,Rebecca J. Nagy,Christine E. Lee,Lesli A. Kiedrowski,Cloud P. Paweletz,Helmy Eltoukhy,Richard B. Lanman,Darya Chudova,AmirAli Talasaz	283
7	The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patientsbreakdown → 2018 ·Clinical Cancer Research ·Oliver A. Zill,Kimberly C. Banks,Stephen R. Fairclough,Stefanie Mortimer,James V. Vowles,Reza Bayat Mokhtari,David R. Gandara,Philip C. Mack,Justin I. Odegaard,Rebecca J. Nagy,Arthur M. Baca,Helmy Eltoukhy,Darya Chudova,Richard B. Lanman,AmirAli Talasaz	271
8	OA06.01 Clinical Utility of Circulating Tumor DNA (ctDNA) Analysis by Digital next Generation Sequencing of over 5,000 Advanced NSCLC Patients 2017 ·Journal of Thoracic Oncology ·(unknown),Kimberly C. Banks,Jonathan W. Riess,Oliver A. Zill,Stefanie Mortimer,Darya Chudova,Justin I. Odegaard,Christine Lee,Rebecca J. Nagy,Helmy Eltoukhy,AmirAli Talasaz,Richard B. Lanman,David R. Gandara	5
9	O.02: Plasma Next Generation Sequencing of Over 5,000 Advanced Non-Small Cell Lung Cancer Patients With Clinical Correlations 2016 ·Journal of Thoracic Oncology ·Philip C. Mack,Kimberly C. Banks,Oliver A. Zill,Stefanie Mortimer,Darya Chudova,Justin I. Odegaard,Christine E. Lee,Rebecca J. Nagy,Helmy Eltoukhy,AmirAli Talasaz,Richard B. Lanman,David R. Gandara	4
10	Case series of EGFR C797S mutations in non-small cell lung cancer identified with cell-free circulating tumor DNA next generation sequencing. 2016 ·Journal of Clinical Oncology ·Stephen R. Fairclough,Oliver A. Zill,Darya Chudova,(unknown),Richard B. Lanman,Kimberly C. Banks,Rebecca J. Nagy,Stefanie Mortimer,Helmy Eltoukhy,AmirAli Talasaz,Suresh S. Ramalingam	2
11	Somatic genomic landscape of over 15,000 patients with advanced-stage cancer from clinical next-generation sequencing analysis of circulating tumor DNA. 2016 ·Journal of Clinical Oncology ·Oliver A. Zill,Stefanie Mortimer,Kimberly C. Banks,Rebecca J. Nagy,Darya Chudova,(unknown),Arthur M. Baca,(unknown),Richard B. Lanman,AmirAli Talasaz,Helmy Eltoukhy,Razelle Kurzrock	8
12	Non-invasive detection of crizotinib resistance in ALK-rearranged lung adenocarcinoma directs treatment with next-generation ALK inhibitors. 2016 ·Journal of Clinical Oncology ·Nnamdi Ihuegbu,Kimberly C. Banks,Stephen R. Fairclough,Oliver A. Zill,Darya Chudova,Richard B. Lanman,Collin M. Blakely	3
13	Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas 2015 ·Cancer Discovery ·Oliver A. Zill,Claire Greene,Dragan Sebisanovic,(unknown),Jim Leng,Mary Vu,Andrew Hendifar,Zhen Wang,Chloé E. Atreya,Robin Kate Kelley,Katherine Van Loon,Andrew H. Ko,Margaret A. Tempero,Trever G. Bivona,Pamela N. Münster,AmirAli Talasaz,Eric A. Collisson	202
14	Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients 2015 ·Oncotarget ·Seung Tae Kim,Won‐Suk Lee,Richard B. Lanman,Stefanie Mortimer,Oliver A. Zill,Kyoung-Mee Kim,Kee Taek Jang,Seok Hyung Kim,Se Hoon Park,Joon Oh Park,Young Suk Park,Ho Yeong Lim,Helmy Eltoukhy,Won Ki Kang,Woo Yong Lee,Hee‐Cheol Kim,Keunchil Park,Jeeyun Lee,AmirAli Talasaz	63
15	Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNAbreakdown → 2015 ·PLoS ONE ·Richard B. Lanman,Stefanie Mortimer,Oliver A. Zill,Dragan Sebisanovic,René López,Sibel Blau,Eric A. Collisson,Stephen G. Divers,Dave S.�B. Hoon,Scott Kopetz,Jeeyun Lee,Petros Nikolinakos,Arthur M. Baca,Bahram G. Kermani,Helmy Eltoukhy,AmirAli Talasaz	470
16	Abstract C80: Development of EGFR C797S mutation in serial liquid biopsy assessments in the clinical practice setting 2015 ·Molecular Cancer Therapeutics ·Kathryn F. Mileham,Qing Zhang,Carol Farhangfar,Daniel Haggstrom,Stephen R. Fairclough,Oliver A. Zill,Daniel R. Carrizosa,Richard B. Lanman,Edward S. Kim	1
17	Evolutionary Analysis of Heterochromatin Protein Compatibility by Interspecies Complementation in Saccharomyces 2012 ·Genetics ·Oliver A. Zill,Devin R. Scannell,(unknown),Meru J. Sadhu,Jasper Rine	6
18	The Awesome Power of Yeast Evolutionary Genetics: New Genome Sequences and Strain Resources for theSaccharomyces sensu strictoGenus 2011 ·G3 Genes Genomes Genetics ·Devin R. Scannell,Oliver A. Zill,Antonis Rokas,Célia Payen,Maitreya J. Dunham,Michael B. Eisen,Jasper Rine,Mark Johnston,Chris Todd Hittinger	237
19	Impact of Chromatin Structures on DNA Processing for Genomic Analyses 2009 ·PLoS ONE ·Lenny Teytelman,Bilge Özaydın,Oliver A. Zill,Philippe Lefrançois,M Snyder,Jasper Rine,Michael B. Eisen	94
20	Interspecies variation reveals a conserved repressor of α-specific genes in Saccharomyces yeasts 2008 ·Genes & Development ·Oliver A. Zill,Jasper Rine	23

About Oliver A. Zill

Oliver A. Zill is a scholar working on Cancer Research, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (17 papers), Lung Cancer Treatments and Mutations (13 papers) and Genetic factors in colorectal cancer (9 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (717 citations) and Pulmonary and Respiratory Medicine (857 citations). Oliver A. Zill has collaborated with scholars based in United States, Switzerland and South Korea. Frequent co-authors include Richard B. Lanman, Stefanie Mortimer, Helmy Eltoukhy, Jasper Rine, Arthur M. Baca, Kimberly C. Banks, AmirAli Talasaz, AmirAli Talasaz, Eric A. Collisson and Dragan Sebisanovic. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Genes & Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact